Hefei Lifeon Pharmaceutical Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Hefei Lifeon Pharmaceutical Co., Ltd. carries a market capitalization of 3.01B, placing it among publicly traded companies globally. Its enterprise value stands at 4.24B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.01B |
| Enterprise Value | 4.24B |
Share Statistics
Hefei Lifeon Pharmaceutical Co., Ltd. currently has 228.22M shares outstanding.
| Shares Outstanding | 228.22M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Hefei Lifeon Pharmaceutical Co., Ltd. trades at a trailing price-to-earnings ratio of 34.28. The price-to-sales ratio is 3.75, and the price-to-book ratio stands at 3.64.
| PE Ratio | 34.28 |
| PS Ratio | 3.75 |
| PB Ratio | 3.64 |
| P/TBV Ratio | 2.48 |
| P/FCF Ratio | 51.48 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Hefei Lifeon Pharmaceutical Co., Ltd. trades at an EV/EBITDA multiple of 32.92 and an EV/FCF ratio of 47.05. The EV/Sales ratio of 3.53 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 32.92 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.53 |
| EV / EBITDA | 32.92 |
| EV / EBIT | 32.92 |
| EV / FCF | 47.05 |
Financial Position
Hefei Lifeon Pharmaceutical Co., Ltd. maintains a current ratio of 2.28, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 3.68, indicating elevated leverage, while an interest coverage ratio of 46.12 demonstrates strong ability to service its debt obligations.
| Current Ratio | 2.28 |
| Quick Ratio | 0.90 |
| Debt / Equity | 3.68 |
| Debt / EBITDA | 0.57 |
| Interest Coverage | 46.12 |
Financial Efficiency
Hefei Lifeon Pharmaceutical Co., Ltd. posts a return on equity of 10.93 and a return on invested capital of 5.57.
| Return on Equity (ROE) | 10.93 |
| Return on Assets (ROA) | 5.01 |
| Return on Invested Capital (ROIC) | 5.57 |
| Return on Capital Employed (ROCE) | 9.60 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.82 |
Taxes
Over the trailing twelve months, Hefei Lifeon Pharmaceutical Co., Ltd. has paid 15.00M in income taxes, reflecting an effective tax rate of 10.49.
| Income Tax | 15.00M |
| Effective Tax Rate | 10.49 |
Stock Price Statistics
Hefei Lifeon Pharmaceutical Co., Ltd.'s stock has declined approximately -15.16613% over the past 52 weeks. The 50-day moving average sits at 16.92, while the 200-day moving average is 20.90.
| Beta (5Y) | N/A |
| 52-Week Price Change | -15.16613% |
| 50-Day Moving Average | 16.92 |
| 200-Day Moving Average | 20.90 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Hefei Lifeon Pharmaceutical Co., Ltd. generated 1.20B in revenue and converted that into 131.52M in net income, yielding earnings per share of 0.57. EBITDA reached 128.80M, while operating income came in at 128.80M.
| Revenue | 1.20B |
| Gross Profit | 783.57M |
| Operating Income | 128.80M |
| Pretax Income | 142.95M |
| Net Income | 131.52M |
| EBITDA | 128.80M |
| EBIT | 128.80M |
| Earnings Per Share (EPS) | 0.57 |
Balance Sheet
Hefei Lifeon Pharmaceutical Co., Ltd. holds 485.59M in cash and equivalents against 73.20M in total debt, resulting in a net debt position of -215.41M. Total book value stands at 1.24B, with working capital of 694.44M providing operational flexibility.
| Cash & Cash Equivalents | 485.59M |
| Total Debt | 73.20M |
| Net Debt | -215.41M |
| Equity (Book Value) | 1.24B |
| Book Value Per Share | 5.55 |
| Working Capital | 694.44M |
Cash Flow
After subtracting -87.59M in capital expenditures, free cash flow totaled -87.59M - equivalent to -0.39 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -87.59M |
| Free Cash Flow | -87.59M |
| FCF Per Share | -0.39 |
Margins
Hefei Lifeon Pharmaceutical Co., Ltd. operates with a gross margin of 65.17, reflecting its pricing power and cost economics. The operating margin of 10.71 and net profit margin of 10.94 provide insight into operational efficiency.
| Gross Margin | 65.17 |
| Operating Margin | 10.71 |
| Pretax Margin | 11.89 |
| Profit Margin | 10.94 |
| EBITDA Margin | 10.71 |
Dividends & Yields
The company's payout ratio of 96.53 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.54 |
| Dividend Yield | N/A |
| Payout Ratio | 96.53 |
| Shareholder Yield | 2.52 |
| FCF Yield | 1.94 |
Stock Splits
Hefei Lifeon Pharmaceutical Co., Ltd.'s most recent stock split took place on May 29, 2026 with a 5:6 split ratio.
| Last Split Date | 5/29/2026 |
| Split Ratio | 5:6 |
Scores
Hefei Lifeon Pharmaceutical Co., Ltd. posts an Altman Z-Score of 5.66, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 5.66 |